ABT — ABBOTT LABORATORIES
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Dividends
Measured signals that fired on ABT
| date | signal | measured base rate |
|---|---|---|
| 2026-08-19 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-07-20 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-07-16 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-07-14 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-06-04 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-04-30 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-12 | Morrone Louis H. EXECUTIVE VICE PRESIDENT | Discretionary Transaction | 12 | 107.99 | 1.3K |
| 2026-08-11 | Morrone Louis H. EXECUTIVE VICE PRESIDENT | Open-market sale | 5.8K | 109.83 | 642.5K |
| 2026-06-30 | Morrone Louis H. EXECUTIVE VICE PRESIDENT | Shares withheld for tax | 269 | 92.71 | 24.9K |
| 2026-06-27 | Cushman Elizabeth C. EVP, GC AND SECRETARY | Shares withheld for tax | 560 | 94.12 | 52.7K |
| 2026-05-07 | Stratton John G Director | Open-market purchase | 2.0K | 86.82 | 173.6K |
| 2026-04-28 | Moreland Mary K EXECUTIVE VICE PRESIDENT | Discretionary Transaction | 5.3K | 94.41 | 501.7K |
| 2026-04-27 | STARKS DANIEL J Director | Open-market purchase | 10.0K | 92.65 | 926.5K |
| 2026-04-24 | Conroy Kevin T Director | Grant or award | 2.3K | 0.00 | 0 |
| 2026-04-24 | McKinstry Nancy Director | Grant or award | 2.3K | 0.00 | 0 |
| 2026-04-24 | STARKS DANIEL J Director | Grant or award | 2.3K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BlackRock, Inc. | 15.0B | 145.7M |
| VANGUARD CAPITAL MANAGEMENT LLC | 11.6B | 112.9M |
| STATE STREET CORP | 8.2B | 79.6M |
| Capital Research Global Investors | 5.1B | 49.8M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.9B | 47.9M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 4.7B | 45.5M |
| GEODE CAPITAL MANAGEMENT, LLC | 4.0B | 39.1M |
| Capital International Investors | 3.8B | 37.5M |
| MORGAN STANLEY | 3.1B | 30.1M |
| WELLINGTON MANAGEMENT GROUP LLP | 2.8B | 27.1M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 8-K | 2026-08-20 | 2026-08-20 | on EDGAR ↗ |
| 4 | 2026-08-13 | 2026-08-11 | on EDGAR ↗ |
| 144 | 2026-08-11 | — | on EDGAR ↗ |
| 10-Q | 2026-07-28 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-07-16 | 2026-07-16 | on EDGAR ↗ |
| 4 | 2026-07-01 | 2026-06-30 | on EDGAR ↗ |
| 4 | 2026-07-01 | 2026-06-30 | on EDGAR ↗ |
| 4 | 2026-07-01 | 2026-06-30 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson? · 2026-08-23
- Resilient Abbott Laboratories stock holds above $116 as guidance and litigation settlement shape out - Ad-hoc-news.de · 2026-08-22 · Ad-hoc-news.de
- Abbott Bypasses Appeals Process To Settle Ongoing Premature Infant Formula Litigation · 2026-08-21 · benzinga
- Abbott to pay $670 million to settle some preterm infant formula cases · 2026-08-20
- Abbott in $670M settlement for some NEC infant formula claims · 2026-08-20
- Abbott Laboratories (ABT) filed form 8-K · 2026-08-20 · SEC EDGAR
Others in Healthcare
Ask the AI about ABT
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →